AlphaYouTR
Insider selling
Third Rock Ventures V, L.P. sold $11.1M of Rapport Therapeutics, Inc. (RAPP) stock
Third Rock Ventures V, L.P., 10% owner of Rapport Therapeutics, Inc. (RAPP), sold 276,513 shares of RAPP stock worth $11.1M, per an SEC Form 4 filed May 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 7, 2026, 4 days before it was made public.
RAPP has moved -0.7% since the trade date, from $39.93 to $39.66 (Sep 21, 2026 close).
- Traded
- May 7, 2026
- Disclosed
- May 11, 2026
- Filing delay
- 4 days
- Price since
- -0.7%
- Role
- 10% owner
- Source
- SEC Form 4
More RAPP insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.